United States · Series B startup

Who invested in House Rx

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Raised 12 months ago

Funding summaryUpdated 26 Oct 2026

$55Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $55MNov 2025
Investors
5
See who backed them

The rounds

  1. Nov 2025

Founders and team

From House Rx's own website: 1 founder, 7 on the team.

Ogi KavazovicCEO & Co-Founder
  • Bob PhelanCEO, Cancer Specialists of North Florida
  • Alda PontesChief of Staff
  • Denali CahoonChief Pharmacy & Operating Officer
  • Raghu BukkapatnamChief Commercial Officer
  • Salman SuhailVP, Product
  • Tamiko YamataniVP, Customer Operations
  • Dan LaddSenior Director, Infrastructure & Reliability Engineering

Everyone who backed them

Khosla VenturesVC firm1round
Maverick VenturesVC firm1round
1984 VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about House Rx

Who invested in House Rx?

House Rx's investors include New Enterprise Associates, Khosla Ventures, Bessemer Venture Partners, Maverick Ventures and 1984 Ventures.

How much has House Rx raised?

House Rx has raised $55M across 1 round since 2025.

When did House Rx last raise?

House Rx's most recent round was a Series B of $55M in Nov 2025.

What was House Rx's biggest round?

Its most recent round, $55M in Nov 2025, is also its largest on record.

Who backed House Rx first?

House Rx's first round on record, in Nov 2025, was backed by New Enterprise Associates, Khosla Ventures and Bessemer Venture Partners and 2 others.

What stage is House Rx at?

House Rx's latest named round is a Series B, in Nov 2025.

Where is House Rx based?

House Rx is based in the United States.

Companies like House Rx

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.